Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Short

Showing results (91-100 of 346) with videos related to

Pageof 35
Sort By:
The Lancet. Haematology|October 23, 2021
Harnessing the benefits of available targeted therapies in acute myeloid leukaemiaHagop Kantarjian, Nicholas J Short, Courtney DiNardo, et al.
Leukemia|April 24, 2025
Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia/lymphoma (B-ALL): insights from a decade of national dataTing Zhou, Nicholas J Short, Nitin Jain, et al.
International Journal of Hematology|May 15, 2024
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemiaHiroki Akiyama, Hagop Kantarjian, Elias Jabbour, et al.
American Journal of Hematology|May 2, 2020
Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patientMarisa J L Aitken, Christopher B Benton, Feng Wang, et al.
Cancer|May 5, 2025
The evolving therapeutic revolution in adult acute lymphoblastic leukemiaHagop Kantarjian, Nitin Jain, Mark R Litzow, et al.
American Journal of Hematology|June 6, 2020
Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphomaBachar Samra, Ahmad S Alotaibi, Nicholas J Short, et al.
Blood Advances|January 24, 2025
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US expertsNicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.
Blood Cancer Journal|September 19, 2024
Current status and research directions in acute myeloid leukemiaHagop Kantarjian, Gautam Borthakur, Naval Daver, et al.
Leukemia & Lymphoma|October 12, 2022
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungalsKayleigh R Marx, Caitlin R Rausch, Alexandra R Lovell, et al.
Blood|December 3, 2025
Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemiaRoberta S Azevedo, Elias Jabbour, Hagop M Kantarjian, et al.
Pageof 35

Showing results (91-100 of 346) with videos related to

Sort By:
Pageof 35
The Lancet. Haematology|October 23, 2021
Harnessing the benefits of available targeted therapies in acute myeloid leukaemiaHagop Kantarjian, Nicholas J Short, Courtney DiNardo, et al.
Leukemia|April 24, 2025
Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia/lymphoma (B-ALL): insights from a decade of national dataTing Zhou, Nicholas J Short, Nitin Jain, et al.
International Journal of Hematology|May 15, 2024
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemiaHiroki Akiyama, Hagop Kantarjian, Elias Jabbour, et al.
American Journal of Hematology|May 2, 2020
Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patientMarisa J L Aitken, Christopher B Benton, Feng Wang, et al.
Cancer|May 5, 2025
The evolving therapeutic revolution in adult acute lymphoblastic leukemiaHagop Kantarjian, Nitin Jain, Mark R Litzow, et al.
American Journal of Hematology|June 6, 2020
Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphomaBachar Samra, Ahmad S Alotaibi, Nicholas J Short, et al.
Blood Advances|January 24, 2025
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US expertsNicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.
Blood Cancer Journal|September 19, 2024
Current status and research directions in acute myeloid leukemiaHagop Kantarjian, Gautam Borthakur, Naval Daver, et al.
Leukemia & Lymphoma|October 12, 2022
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungalsKayleigh R Marx, Caitlin R Rausch, Alexandra R Lovell, et al.
Blood|December 3, 2025
Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemiaRoberta S Azevedo, Elias Jabbour, Hagop M Kantarjian, et al.
Pageof 35